
October 1, 2026 | 9 min read
Tonbo Imaging India IPO: Date, Price, Lot Size, Offer Structure, Financials and Key Details
Tonbo Imaging India is a defence electronics and optronics company that designs electro optical systems for tactical and platform applications. Its products span weapon sights, observation and targeting systems, stabilised multi-sensor platforms, seekers and other imaging-led solutions used by armed forces, security agencies and defence OEMs. Tono Imaging India has filed a Draft Red Herring Prospectus dated 4 August 2026. The proposed IPO is unusual in one important respect: it is entirely an offer for sale of up to 18,085,246 equity shares. There is no fresh issue. This means the listing may improve liquidity and visibility for the company, but it will not bring new capital into the business or reduce debt directly.
For investors, the central question is therefore less about what the IPO funds will finance and more about the quality and durability of Tonbo's underlying economics. The company has strong reported margins and a technology-heavy product portfolio, but it also operates in a tender-driven defence market where revenue can be lumpy and working-capital requirements can be substantial.
Tonbo Imaging India IPO dates and launch details
The company is currently at the DRHP stage. The price band, minimum bid lot and final bidding dates have not yet been announced.
Detail | Information |
|---|---|
Filing stage | DRHP dated 4 August 2026, listed by SEBI on 14 August 2026 |
Issue type | 100% Offer for Sale |
Total offer | Up to 18,085,246 equity shares |
Fresh issue | None |
Offer for Sale | Up to 18,085,246 equity shares |
Face value | ₹2 per equity share |
Price band | Yet to be announced |
Minimum bid lot | Yet to be announced |
IPO dates | Yet to be announced |
Listing exchanges | |
Registrar | |
BRLMs |
What the IPO structure means
Because the issue is entirely an OFS, the company will not receive any of the offer proceeds. The selling shareholders will receive the proceeds in proportion to the shares sold, after applicable offer-related expenses and taxes. The stated objects are to obtain the benefits of listing and provide liquidity to existing shareholders.
This distinction matters. A fresh issue can fund capex, working capital or debt repayment. Tonbo will not receive that balance-sheet support from this IPO. Investors therefore need to assess the company's existing cash generation, working-capital profile and funding needs on their own merits.
About Tonbo Imaging India
Tonbo focuses on design, technology ownership, product engineering and system integration. Large-scale manufacturing is outsourced to electronic manufacturing service partners, while prototypes, system integration and qualification testing remain in-house. This makes the model more asset-light than a conventional defence manufacturer, but also creates dependence on external manufacturing partners and component supply chains.
- Tactical systems: electro-optical sights and observation/targeting systems designed for dismounted soldiers.
- Platform systems: integrated surveillance, reconnaissance and targeting systems for larger platforms.
- R&D intensity: 133 of 339 permanent employees were in product design and development as of 31 March 2026.
- Global deployment: more than 28,000 tactical systems had been deployed across 24 countries as of 31 March 2026.
- Outsourced scale-up: Tonbo uses EMS partners such as Kaynes and Avalon for mass production while retaining design, integration and testing capabilities internally.
- Imported inputs: 63.49% of raw-material procurement in FY26 came from international suppliers, making component availability and currency movements relevant operating variables.
The business economics: technology-led, but tender-driven
Tonbo is not a recurring-revenue defence platform. Most contracts are won through competitive tenders and are typically linked to specific procurement requirements. That makes order wins, execution schedules and customer budgets more important than simple capacity utilisation.
The product mix is also changing. Tactical-system revenue fell from ₹359.27 crore in FY24 to ₹211.68 crore in FY26, while platform-system revenue rose from ₹12.70 crore to ₹144.81 crore over the same period. The shift towards platform systems broadens the revenue base, but it can also make quarterly and annual performance more dependent on the timing of large programmes.
Tonbo Imaging India financials
The following table uses the prospectus financial statements and applies the established mStock free-cash-flow methodology. Amounts are in ₹ crore.
Period | Revenue | EBITDA | Net Profit | Cash Flow from Operations | Free Cash Flow |
|---|---|---|---|---|---|
FY24 | 428.19 | 112.32 | 68.54 | 78.33 | (108.94) |
FY25 | 469.08 | 139.06 | 72.76 | (136.12) | (162.79) |
FY26 | 362.65 | 104.62 | 50.88 | (63.22) | (102.17) |
What stands out in the financials?
Revenue rose 9.55% in FY25 before declining 22.69% in FY26. The prospectus links part of the FY26 weakness to the deferment of a significant export order because of logistical disruptions arising from the West Asia crisis. Export contribution fell sharply from 65.52% of revenue in FY25 to 5.57% in FY26, while the domestic business became the dominant revenue source.
Margins remain high for a manufacturing-linked business. Gross margin was 51.05% in FY26 and EBITDA margin was 28.85%. This reflects the economics of a model where design, IP, system engineering and integration are retained while mass manufacturing is outsourced. However, the margin profile can move with product mix, tender pricing and procurement costs, so it should not be viewed as a fixed structural margin.
Profitability also softened with revenue. PAT fell from ₹72.76 crore in FY25 to ₹50.88 crore in FY26. ROCE declined from 27.41% to 14.54% over the same period, partly reflecting weaker earnings and a larger capital base.
Tonbo Imaging India Cash conversion
Tonbo reported negative operating cash flow in both FY25 and FY26 despite remaining profitable. Working-capital days increased from 152 days in FY24 to 280 days in FY25 and 517 days in FY26. At 31 March 2026, net trade receivables stood at ₹211.66 crore and inventories at ₹219.49 crore.
The prospectus attributes the elevated FY26 receivables to the concentration of revenue recognition in the final quarter and says subsequent collections reduced the outstanding balance. It also links higher inventory to the deferred export order and inventory built in anticipation of FY27 opportunities. Even so, the widening working-capital cycle remains an important point to track because defence orders can absorb cash well before customer collections arrive.
Free cash flow was negative in all three years under the mStock methodology. FY24 was particularly affected by ₹184.59 crore of payments towards intangible assets and capital work-in-progress. Negative FCF does not automatically imply a weak business, especially where product development is being funded, but investors should monitor whether R&D and working-capital investment translate into sustained order conversion and cash generation.
Debt and the OFS-only IPO
Total borrowings stood at ₹116.06 crore as of 31 March 2026, comprising current borrowings. Because the IPO is entirely an OFS, the issue will not directly reduce this debt or inject funds into the company. Any improvement in leverage will therefore have to come from internal cash generation or other financing decisions.
Order book, bidding and customer concentration
Tonbo had a confirmed order book of ₹314.14 crore as of 30 June 2026, comprising ₹231.77 crore of domestic orders and ₹82.37 crore of overseas orders. It also received another ₹7.10 crore of orders during July 2026. The order book gives near-term revenue visibility, but the company itself cautions that tender-driven defence orders can be delayed, modified or cancelled.
Metric | FY24 | FY25 | FY26 |
Largest customer share of revenue | 44.11% | 57.07% | 13.78% |
Top 5 customer share | 72.19% | 86.36% | 53.03% |
Top 10 customer share | 84.50% | 95.49% | 77.83% |
Bid-to-win ratio | 40.91% | 35.94% | 31.30% |
Confirmed order book (₹ crore) | 563.14 | 218.61 | 279.02 |
Customer concentration improved materially in FY26, but it remains high. The top 10 customers still contributed 77.83% of revenue. Defence procurement is also not annuity-like: contracts are typically short-term and specific to individual requirements, which means Tonbo must continually qualify for and win new programmes.
The FY26 bid-to-win ratio was 31.30%, down from 40.91% in FY24. That does not necessarily signal weaker competitive positioning because the denominator includes active and lost bids, but it reinforces how central tender conversion is to the revenue model.
Sector context: defence indigenisation meets procurement cyclicality
The prospectus highlights policy support for domestic design, defence indigenisation and export participation. Tonbo's technology-led positioning and overseas deployments give it exposure to both Indian and international procurement opportunities.
At the same time, defence electronics is not a smooth consumer-style demand market. Procurement depends on budgets, trials, qualification, security clearances and programme schedules. Revenue can therefore shift meaningfully between years even if the underlying technology platform remains competitive.
Key considerations for investors
Strengths
- Technology and IP-led model with substantial in-house product design, system integration and qualification capability.
- A sizeable R&D organisation, with 133 product design and development employees as of March 2026.
- Global deployment history across 24 countries and more than 28,000 tactical systems deployed by March 2026.
- Product-mix diversification, with platform-system revenue growing sharply over FY24-FY26.
- An outsourced EMS model that can allow production to scale without the fixed-asset intensity of a fully integrated manufacturer.
Risks
- The IPO is entirely an OFS, so no new capital will enter the company.
- Operating cash flow was negative in FY25 and FY26, while working-capital days rose to 517 in FY26.
- Revenue and the order book remain concentrated among a limited number of defence customers.
- Tender wins are not recurring annuity contracts; delays, cancellations and programme slippages can make revenue volatile.
- Tonbo relies on external EMS partners for large-scale production and imported components for a majority of raw-material procurement.
- Two contracts aggregating to ₹28.08 crore were cancelled across FY25 and FY26 because a product with a sizeable R&D component could not be developed within the specified timeline.
- Export contribution can be volatile and is exposed to logistics, geopolitics, local partners and country-specific procurement conditions.
Opportunities
- India's defence-indigenisation push can expand the addressable market for domestically designed electro-optical systems.
- The growing contribution from platform systems may deepen Tonbo's role in larger integrated defence programmes.
- A recovery in export execution could diversify revenue after FY26's sharp domestic skew.
- The company's R&D pipeline spans advanced imaging, seekers, stabilised systems and directed-energy technologies, creating potential for new product families if qualification and commercialisation are successful.
Conclusion
Tonbo Imaging India combines high reported margins, proprietary defence-electronics capabilities and an asset-light manufacturing model with a much more volatile cash-flow profile than the profit-and-loss statement alone suggests. The shift towards platform systems, a ₹314.14 crore June 2026 order book and a broad international deployment record provide useful operating context. But cash conversion, customer concentration and tender execution remain central monitorables.
The IPO structure also matters. Since the issue is entirely an OFS, the company will not receive fresh capital. Investors evaluating the eventual offer will therefore need to assess the final valuation against the durability of margins, order conversion, working-capital normalisation, cash generation and the risks inherent in defence procurement. The price band and lot size are yet to be announced at the DRHP stage.
FAQ
At the DRHP stage, the IPO comprises an offer for sale of up to 18,085,246 equity shares. The rupee value of the offer will depend on the final price band, which has not yet been announced.

